NEWS
18th of August 2023: New publication out!
Chene, A.; Desrames, A.; Tomlinson, A.; Ruffie, C.; Tangy, F.; Gamain, B., An ACE2-based bimodular fusion protein enables reorientation of endogenous anti-Epstein-Barr virus antibodies towards SARS-CoV-2 Spike. J Infect Dis 2023.http://dx.doi.org/10.1093/infdis/jiad329
28th - 29th of June 2022: ADVANCE-VAC4PM Kickoff meeting
New European-African partnership to contribute to the fight against placental malaria
€10 million mobilised by the ADVANCE-VAC4PM consortium to advance the development of a safe, effective, and affordable placental malaria vaccine to protect pregnant women and their babies. ADVANCE-VAC4PM received funding from the European Union's Horizon Europe research and innovation programme under grant agreement N° 101057882
HOME | Advance Vac4pm (advance-vac4pm.eu)
Group Picture at the Kickoff Meeting in Heidelberg
19th of April 2022: New funding!
Glad to share that the FRM is going to labellized our team as an FRM team for the next 3 years !
https://www.frm.org/upload/chercheurs/pdf/resultats-equipes-frm2022.pdf
11th of February 2022: Press Release
A Novel Immunotherapy Approach Redirects Epstein-Barr Antibodies toward Disease-Causing Cells
Our manuscript on a novel strategy to redirect Epstein-Barr Antibodies toward Disease-Causing Cells is out!
11th of February 2022: New publication out!
Gamain, B.; Brousse, C.; Rainey, N. E.; Diallo, B. K.; Paquereau, C. E.; Desrames, A.; Ceputyte, J.; Semblat, J. P.; Bertrand, O.; Gangnard, S.; Teillaud, J. L.; Chene, A., BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells. Science Advances 2022, 8 (6), eabl4363.http://dx.doi.org/10.1126/sciadv.abl4363
11th of November 2021: New publication out!
Keitany, G. J.; Jenkins, B. J.; Obiakor, H. T.; Daniel, S.; Muehlenbachs, A.; Semblat, J. P.; Gamain, B.; Doritchamou, J. Y. A.; Desai, S. A.; MacDonald, N. J.; Narum, D. L.; Morrison, R.; Saveria, T.; Vignali, M.; Oleinikov, A. V.; Fried, M.; Duffy, P. E., An invariant protein that co-localizes with VAR2CSA on Plasmodium falciparum-infected red cells binds to chondroitin sulfate A. J Infect Dis 2021.http://dx.doi.org/10.1093/infdis/jiab550
4th of November 2021: New Grant!
Glad to share that the GHIT fund is supporting our #placental # malaria #vaccine to the next step !
20th of March 2021: New publication out!
Gamain, B.; Chene, A.; Viebig, N. K.; Tuikue Ndam, N.; Nielsen, M. A., Progress and Insights Toward an Effective Placental Malaria Vaccine. Front Immunol 2021, 12, 634508.http://dx.doi.org/10.3389/fimmu.2021.634508
27th of February 2021: New publication out!
Alonso, S.; Vidal, M.; Ruiz-Olalla, G.; Gonzalez, R.; Jairoce, C.; Manaca, M. N.; Vazquez-Santiago, M.; Balcells, R.; Vala, A.; Ruperez, M.; Cistero, P.; Fuente-Soro, L.; Angov, E.; Coppel, R. L.; Gamain, B.; Cavanagh, D.; Beeson, J. G.; Nhacolo, A.; Sevene, E.; Aponte, J. J.; Macete, E.; Aguilar, R.; Mayor, A.; Menendez, C.; Dobano, C.; Moncunill, G., HIV infection and placental malaria reduce maternal transfer of multiple antimalarial antibodies in Mozambican women. J Infect 2021.http://dx.doi.org/10.1016/j.jinf.2021.02.024
09th of February 2021: New publication out!
Tomlinson, A.; Semblat, J. P.; Gamain, B.; Chene, A., VAR2CSA-Mediated Host Defense Evasion of Plasmodium falciparum Infected Erythrocytes in Placental Malaria. Front Immunol 2021, 11, 624126.http://dx.doi.org/10.3389/fimmu.2020.624126
23rd of October 2020: Arnaud Chêne has been awarded a permanent researcher position at INSERM!
Congratulations Arnaud!